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INTRODUCTION 
( During the 10 years since the first orthotopic hepatic transplantation was per-Ionned in Denver, over 200 patients have had liver replacement throughout the I w«Id, according to the American CoUege of Surgeons Registry.6 We have con-lributed 82 cases to this total. at a rate of about 10 per year since 1967, when 
die fmllong-term survivof was treated. 14 
In this communication, the survivals for these 82 recipients will be recorded. In 
idJltion, current policy will be reexamined in 3 areas on the basis of recently 
-.:quired or summarized data. Two of the questions pertain to candidacy for liver 
tru1splantation with particular reference to patients with alcoholic liver disease 
and. 10 recipients who possess performed antidonor antibodies. Finally, a reap-
• rr111lI of our experience with biliary reconstruction has led to modifications in 
'" approach to this major area of technical failure. 
R &: H. H. HENNETCEUSER, Eds.'''l. Intemltiulll--"T-
I the Liver. Freiburg, Germany. SURVIVAL STATISTICS 
Tbr I· and 2-year survivors from our 82 consecutive cases have been 18 and 9 
IItSpectively (TABLE I). Our longest survivor of the 13 still alive is now nearly 5 
, tun posttransplantation, another is 4! years, and 2 others have passed the 3· 
• Jqr marie 
The 10 late deaths, the causes for which are given in TABLE 2, have occurred 
from 12 to 41 months postoperatively. The latest mortality (OT 19), at 3! years, 
~ "'ork was supported by research grants from the Veterans Administration; by grants 
-= 1 '()8898 and AM-07772 from the National Institutes of Health; by grants RR-00051 
__ L R.()()069 from the General Clinical Research Centers Program of the Division of Re-i - ... Resources, National Institutes of Health. 
, 
; 
146 Annals New York Academy of Sciences 
TABLE 1 
Cases of Orthotopic Uver Transplantation Treated in Denver 
Lived 
Number 1 Year 2 Years 
1963-1966 6 0 0 
1967 6 1 0 
1968 12 5 2 
1969 6 2 1 
1970 10 2 1 
1971 11 2 2 
1972 11 5 3 
1973 13 1 0 
1974 (to Aprill) 7 0 0 
Total 82 18 9 
-
-
followed a bout of Hemophilus septicemia. At autopsy, the homograft arteries 
had occlusive lesions similar to those seen in renal transplants. 13 
The most important causes of the high acute failure rate have been technical 
of which complications of biliary duct reconstruction are the most common: 
The important contribution of faulty biliary drainage to mortality and mor· 
bidity, including cholangitis, will be discussed in a later section. After technical 
failures, rejection and systemic infection lead the list. 
TRANSPLANTATION FOR ALCOHOLIC LIVER DISEASE 
Early in our experience it was suggested that patients with alcoholic liver dis-
ease presented an especially poor candidacy for hepatic transplantation.14 The 
reasons for this opinion were twofold. First, cirrhotic patients have a predictably 
TABLE 2 ... ~~ 
The Present Status of 18 I·Year Survivors After Orthotopic Liver Transplantation. 
Eight Are Still Alive from 14 to 58 Months. The Other 10 Eventually Died from IJ', 
OTNO. 
15 
29 
8 
58 
16 
14 
54 
36 
13 
19 
the Causes Listed Below. 
Time of Death 
(Months) 
12 
12 
13 
131 
131 
14 
19 
20 
30 
41 
Cause of Death 
Recu Trent cancer 
Serum hepatitis and liver failure 
Recurrent cancer 
? Chronic rejection 
? Recurrent hepatitis 
Rejection and liver failure 
Recurrent cancer 
Multiple liver abscesses necessitating '.' 
retransplantation 
Systemic Nocardill infection and chronic 
aggressive hepa titis 
Rejection and liver failure following 
retransplantation 
Hemophilus septicemia and secondary liver 
and renal failure 
,my of Sciertces 
dtion Treated in Denver 
Lived 
2 Years Alive No. 
o 
o 
2 
1 
1 
2 
3 
o 
o 
9 
o 
o ~:: 
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1 
1 
2 
3 ~ 3 . , 
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- Alcoholic Nonalcoholic Total 
No. of Patients 10 72 82 
Alive 1- tl 13 
Dead 9 60 69 
Mean Survival 
of those who died 29 days 136 days 122 d~vf 
=;3 weeks posttransplantation. 
higher operative risk, in part due to the frequency of pulmonary and other in-
fectious complications. Secondly, for all but those patients with clearly terminal 
esophageal variceal hemorrhage, hepatic coma or advanced secondary renal 
failure, uncertainty about the natural course of the disease usually leads to a 
decision against transplantation until such time as the patient's condition becomes 
patently hopeless. Many then die before a suitable liver becomes available; the 
few who are given transplants enter the operating room in a moribund state. 
Of the 82 consecutive recipients of hepatic homografts, 1 was treated for 
alcoholic hepatitis and 9 carried the diagnosis of Laennec's cirrhosis without con-
current bepatoma (TABLE 3). Nine of the 10 patients have died, from 3 to 121 
(mean 29) days posttransplantation; the only surviving recipient is in good condi-
tion 4 weeks postoperatively. In contrast, 12 of the 72 patients with transplants 
for nonalcoholic liver disease are still alive from a few weeks to nearly S years 
later. The mean survival of the patients in the nonalcoholic group who have died 
is more than 4 times that of the alcoholic recipients (TABLE 3). 
The causes of death for the alcoholic patients are given in TABLE 4. Two 
deaths were the result of complications of biliary reconstruction (see later), and 
3 were related to homograft rejection. Of the remaining 4 patients, 2 died in 
OTNo. 
22 
28 
32 
39 
40 
62 
70 
75 
81 
82 
TABLE 4 
Duration of Survival and Cause of Death in 10 Alcoholic Recipients 
of Hepatic Homografts 
Age Survival 
(Years) (Days) Cause of Death 
33 10 Biliary obstruction 
Disruption of choledochoduodenostomy, 
39 13 bile peritonitis 
46 3 Unexplained coma 
47 26 Unrelieved preexisting coma 
Rejection, pneumonitis, 
44 32 petechial hemorrhages of CNS 
Rejection and liver failure, 
44 121 pulmonary emboli 
40 34 Pneumonitis 
48 8 Rejection and liver failure 
AJpergillus pneumonitis with 
47 15 dissemination 
37 Alive 
(4 weelcs) 
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coma, which was unrelieved by transplantation or which evolved immediately 
postoperatively, and 2 succumbed to pulmonary infectious complications. 
CURRENT POLICY 
If liver transplantation is to succeed in patients with alcoholic cirrhosis, poten-
tial recipients must be selected earlier, treated aggressively to prevent or correct 
infectious, pulmonary, and other complications, and given transplants before 
their condition has markedly deteriorated. The latest patient (OT 82) in the 
alcoholic group met these criteria, and his early postoperative convalescence has 
been untroubled. Despite the otherwise poor results to date, we will continue to 
consider the occasional patient with alcoholic liver disease with a hopeless prog-
nosis, but who is not moribund and does not have potentially lethal infectious or 
other complications, as an acceptable candidate for liver transplantation. 
CANDIDACY OF RECIPIENTS WITH PREFORMED ANTIDONOR ANTIBODIES 
Hyperacute Rejection of Hepatic Homografts 
The pathophysiology of hyperacute rejection has been well worked out in re-
cent years. The initiating event is apparently fixation of preformed antidonor 
antibody to the transplant. This was flJ'St noted in kidneys (which contain blood-
group antigens) transplanted to ABO-incompatible recipients. II In more recent 
years, the predominant cause of hyperacute rejection has been the presence in 
the serum of the recipient of antigraft cytotoxic antibodies, as was first described 
by Terasaki l5 and confirmed by Kissmeyer-Nielsen? and others.U,I? 
In the laboratory, a form of hyperacute rejection can be produced by trans-
planting organs between widely disparate species, as for example from pigs to 
dogs." Canine serum contains heterospecific antiporcine cytotoxic antibodies that 
rapidly affix to the graft, setting into motion a chain of events that destroys it in 
minutes. 
With either heterografts or homografts transplanted to recipients that possess 
preformed antigraft antibodies, the actual destruction of the organ is a complex 
process in which formed blood elements and clotting factors are entrapped by 
the graft. 5,10,12 The resulting occlusion of the major vessels ca.uses ischemic ne- . 
crasis, which gives a characteristic purple or mottled appearance to the tissue. 
Because of the special filtering properties of the renal microvasculature, the . 
kidney is unusually prone to the irreversible consequences of hyperacute rejec- I 
. ~ tlOn. In contrast, there is evidence that the liver may be unusually resistant to . 
this process. For example, pig livers continue to perform rudimentary functions 
for a number of hours while being perfused with human blood. 3 Even in the dif-
ficult pig-ta-dog heterograft model, in which kidneys are grossly rejected in a few 
seconds, the liver often does not suffer this fate until more than an hour has 
elapsed after revascularization. 5 
If the resistance of the liver to hyperacute rejection proves to be sufficiently 
great to permit its transplantation under conditions that would be categorically 
unacceptable for kidneys, an important limitation to the practicality of the pr~ 
cedure may be eased. Patients dying of liver disease, particularly those with 
alcoholic liver disease, as discussed above, usually cannot wait long for their 
homografts. If liver transplantation can be carried out despite preformed anti--
body states, some patients who would otherwise be deprived of treatment might 
no longer be arbitrarily excluded. In this connection, our experience with 6 j 
patients given transplants despite preformed antibodies-of the antiblood group~ 
or the Iymphocytotoxic varieties-will be discussed. J 
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ABO Incompatibility . 
In 1972, 3 patients with ABO-mismatched livers were donors to recimients~ 
whose condition was considered sufficiently grave that they could not wait for a 
compatible organ (TABLE 5). Hyperacute rejection did not occur, and no other1-
obvious adverse consequences were seen. The titers of antigraft isoagglutinina II~ 
were variable, but at least in I case (OT 61) reached prodigious levels (TABLE 6). " 
The 3 patients all eventually died but the pathologic findings in the homografts ':; 
were remarkably minor. The homograft biliary system of one of the patients '."; 
(OT 60) became partially obstructed by the mechanism of cystic duct stenosis 
shown in fiGURE I B; following biliary reconstruction, the recipient died of 
pulmonary and septic complications. The other 2 patients had almost no ab-
normalities in their liver when they died of infectious complications. 
TABLE 6 
Serial Antigraft Isoagglutinin Titers in the 3 Recipients of ABO-Incompatible 
Livers Described in TABLE 4 
Posttransplantation Day 
o 
1 
3 
5 
7 
9 
11 
13 
15 
17 
19 
21 
28 
35 
42 
49 
56 
63 
70 
77 
84 
OT59 
(ANTI-B) 
1:4 
1:4 
1: 1 
I: 1 
1 :1 
1:4 
1:4 
1:4 
1:4 
OT60 
(ANTI-B) 
1:32 
1: 16 
1:4 
1:2 
1:8 
1:64 
1:64 
1 :32 
1:16 
1:8 
1:4 
1:4 
1:2 
1:2 
1:2 
1:2 
1:1 
1:1 
1:2 
1:2 
1:2 
1:2 
1:2 
1:2 
1:8 
1:4 
D-r:r---~D 
1:8 
Cytotoxic Antibodies 
OT61 
(ANTI·A) 
1:512 
1:64 
1:64 
1:2048 
1:8192 
1:8192 
1:4096 
1:2048 
I: 1024 
1: 1024 
1:512 
1:256 
1:128 
The ability of the ABO-incompatible liver to remain healthy under conditions 
that would be predictably harmful to most kidneys is a feature we have also seen 
in another kind of preformed-antibody situation. During the last 2 years, 3 po-
tential liver recipients were found to have in their serum cytotoxins against most 
of the lymphocyte donors of an indifferent screening panel. Thus, the prospect 
of finding a liver donor without a positive cytotoxic antibody crossmatch was 
. considered nil. Consequently, the decision was made to proceed with the trans-
plantations, in the face of positive crossmatches, despite the potentially adverse 
prognostic implications. 
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None of the 3 patients developed hyperacute rejection. They all eventually 
died, however, from P~ weeks to 131 months later (TABLE 7). In 2 cases (OT S8 
and 63) the homograft livers had only minor histopathologic changes at late 
biopsy ~r autopsy. In the third (OT 71), the homograft functioned poorly from 
the start. Although this could have been a manifestation of acute antibody-
mediated rejection, the organ appeared to be severely damaged by ischemia, as 
well as cellular rejection, when removed 10 days after its transplantation. The 
homograft was replaced with a chimpanzee heterograft, against which the 
recipient also had cytotoxins. The chimpanzee liver functioned for most of the 
14 subsequent days of the patient's life. Upon pathologic examination the hetero-
graft was well preserved, with little evidence of rejection. Centrilobular chole· 
stasis was a prominent feature. This was our third trial of chimpanzee-to-man 
transplantation, the other two having been previously reported.",I" 
Current Policy 
Preformed antibody states should be avoided if at all possible. However, the 
experience cited above with recipients having either anti-red cells or cytotoxic 
antibodies against their donors suggests that this kind of positive crossmatch is 
not an absolute but only a relative contraindication for liver transplantation. 
A REAPPRAISAL OF BILIARY RECONSTRUCTION 
As mentioned earlier, complications of biliary reconstruction have claimed 
many of the early posttransplantation casualties. Biliary drainage has been 
reconstituted with several techniques, including cholecystoduodenostomy after 
ligation of the graft common duct, choledochocholedochostomy with or without 
aT-tube, choledochoduodenostomy, and most recently Roux-en-Y cholecysto-
jejunostomy. The lethal complications with these procedures have been of two 
kinds, one mechanical, obvious, and provable, and the other bacteriologic, 
subtle, and as yet speculative. 
Problems of Faulty Biliary Drainage 
Mechanical Problems 
The mechanical biliary duct problems have been obstruction and biliary 
fIstulae. In the 82 cases of orthotopic transplantation, 2S (30%) of the initial 
biliary reconstructions were eventually found to be mechanically unsatisfactory, 
leading to death or early reoperation (TABLE 8). The true incidence of this prob-
lem is probably even higher, since incipient duct problems may not have been 
recognized in those patients dying soon after transplantation. Thirteen of the 25 
patients with established biliary complications were reoperated on and efforts 
made to reconstruct the duct. Only 4 patients recovered from the reinterventions 
and only two are alive today, 3 months and 2 years respectively after 
transplantation. 
There were failures with each kind of reconstruction (TABLE 8). With chole-
cystoduodenostomy (FIGURE 2A), the most frequently employed technique, 
fIstulae were uncommon but 25% of the patients had proved obstruction (TABLE 
8). In a few, acute obstruction was caused by the accidental ligation of the cystic 
duct at the time of donor hepatectomy (FIGURE I A). Delayed obstruction 
(FIGURE IB) of the cystic duct portion of the bile conduit was diagnosed weeks 
to months postoperatively. In some cases, cytomegalovirus (CMV) infection of 
the duct was implicated,S but in most instances no obvious etiologic factor ac-
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FlGURE 2. Schematic representation of the bacterial contamination or lack thereof in 3 
different kinds of biliary reconstruction. (A) Cholecystoduodenostomy. This extremely 
simple operation probably carries the greatest risk of graft infection. (B) Roux-en-Y chole-
cystojejunostomy. This operation protects from hepatic sepsis by placing the new liver at a 
distance from the main gastrointestinal stream by virtue of an isoperistaitic limb of jejunum 
at least 18 inches long. (C) Roux-en-Y choledochojejunostomy. The end-to-end duct-te-bowel 
anastomosis is simple if the duct is dilated (FIGURE 38), as would be the case if a conversion 
became necessary from 8 to C. 
counted for the partial obstruction. With anastomosis of the graft common duct 
to the host duct or duodenum, biliary fistulae developed in about half the re-
cipients. Obstruction has not been documented after these kinds of 
reconstruction. 
Eight primary reconstructions with ooux~n-Y cho!ecystojejunostomy (FIGURE 
2B) have been performed. One acute obstruction was caused by the technical ac-
cident shown in FIGURE IA. A second patient had a delayed partial obstruction 
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of the cystic duct diagnosed by transhepatic cholangiography (FIGURE 3.8). He 
was reexplored and the drainage converted to Roux-en-Y choledochojejunostomy 
(fiGURE 2C). 
Bacteriologic Complications 
With the technical problems discussed above, clinical (and usually histopatho-
logic) evidence of cholangitis was frequently documented. 
Another kind of infectious complication, as yet hypothetical, may occur despite 
• technically satisfactory biliary reconstruction and no morphologic evidence of 
cholangitis. It has been documented that systemic infections and even asympto-
matic bacteremia are common after hepatic transplantation. I. For years, it has 
been suspected that the transplanted liver itself was the portal by which the 
microorganisms gained access to the blood stream, since no other foci of infection 
could be identified and because the kinds of bacteria detected by blood cultures 
in these patients were strikingly similar to those found in dogs and pigs subjected 
to liver injury or hepatic transplantation. I Theoretically. at least, the bacteria 
could have entered the homograft by either of 2 routes, the portal vein or the 
biliary duct system. The latter now seems to be the far more important source. 
The reason for this view lies in the exposed position of the biliary duct system 
in relation to the gastrointestinal flora, as depicted schematically for a chole-
cystoduodenostomy in FIGURE 2A. Once bacteria gain access to the liver by this 
route, they may then escape through a bacteriologically porous liver without 
producing any histopathologically significant cholangitis on the way. If bacteria 
do indeed gain access to the liver and then the circulation via the biliary system, 
then a logical approach would be to place the homograft ducts as far removed 
from the mainstream of the gastrointestinal tract as pOSSible, as in FIGURES 2B 
and 2C. 
Current Policy 
With these technical and bacteriologic considerations in mind, we have evolved 
and are attempting to follow 6 principles in establishing and assessing biliary 
drainage: .(1) preservation of maximum homograft extrahepatic biliary duct tis-
sue; (2) performance of cholangiography in all homografts prior to transplanta-
tion; (3) placement of the liver in a relatively bacteria-free relation to the main-
stream gastrointestinal continuity; (4) avoidance of stents and drains; 
(5) intensification of diagnostic efforts to differentiate between obstruction and 
rejection in the recipient with abnormal liver function; and (6) early reoperation 
for suspicion of obstruction. None of the currently available methods of recon-
struction completely meets all of these objectives, so that considerable indi-
vidualization of care is necessary. 
A Roux-en-Y cholecystojejunostomy (FIGURE 2B), our present procedure of 
choice, does at least partially meet all of the above objectives. If biliary obstruc-
tion later develops. the Roux limb can be detached, the gallbladder removed, 
and an anastomosis performed to the now dilated common duct (FIGURE 2C). 
The most important objection to this approach is that creation of the Roux-
en-Y jejunal limb can be extremely difficult in liver recipients, adding 3-6 hours 
of operating time and considerable additional blood loss to the already lengthy 
and bloody procedure. The reason for this is that in the adult recipient dying of 
hepatic failure, the small-bowel mesentery usually is quite edematous and laced 
With massive collaterals. Under these adverse conditions, it may be the better 
part of valor to perform a simple cholecystoduodenostomy with the objective of 
, 
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reexploring at a later time if the biliary drainage is suspected of being inadequate. 
If at the time of transplantation the gallbladder is found to be defective, we 
would now make a choice between choledochocholedochostomy with T-tube 
stenting and a Roux-en-Y choledochojejunostomy. 
No matter what the initial procedure, an intense suspicion about and investiga-
tion of the cause for postoperative jaundice is the basic principle of postoperative 
management. A simple precaution is to routinely perform intravenous cholangiog-
raphy early in the postoperative period (FIGURE 3A) in order to establish base-
line delineation of the biliary anatomy_ In almost all of our patients who do de-
velop jaundice, transhepatic cholangiography (FIGURE 3B) and percutaneous 
needle biopsy are part of the work-up. Percutaneous transhepatic cholangiography 
has been greatly expedited by using the Chiba needle, introduced in Japan9 ,16 
and now being employed in several American centers. These thin-walled, small-
caliber, flexible needles permit the diagnostic studies to be done with greater 
safety. 
It is not yet established that these changes in policy will improve the results of 
liver transplantation. Our approach is fundamentally different from that proposed 
by Calne, who believes that duct-ta-duct reconstruction over a T-tube and preser-
vation of the Sphincter of Oddi when possible, will be the better solution to the 
technical and infectious complications of biliary drainage. 2 The fact that dif-
ferent methods are being tried to solve a generally recognized set of problems 
should be an advantage in evolving solutions that can be eventually agreed upon 
and applied by all. 
SUMMARY 
Eighty-two patients have been treated by orthotopic hepatic transplantation in 
Denver since 1963. Eighteen and nine patients have lived for I year and 2 years 
posttransplantation, respectively. Thirteen recipients are still alive from 3 weeks 
to almost 5 years postoperatively. 
Current policy has been ree~amined in 3 areas in light of this experience. First, 
only the occasional potential recipient with alcoholic liver disease, free of in-
fectious or other complications, is an acceptable candidate for this procedure. 
Second, the presence in the. recipient's serum of preformed anti-red cell or 
lymphocytotoxic antibodies to his donor is Ii relative, butnotagy~solute; 
contraindication to hepatic transplantation, since the liver appears to be more 
resistant to hyperacute rejection than the kidney. Finally, a 6-point program has 
been outlined for establishing and evaluating bile drainage, in order to prevent or 
. FIGURE 3. Posttranspiantation cholangiographic studies. (A) Intravenous cholangiogram 
m a 47-year-old recipient of a hepatic homograft, the biliary drainage for which was with 
Roux-en-Y cholecystojejunostomy (FIGURE 2B). The patient's liver function studies were 
normal at the time of the examination. However, the fmdings of a very slightly dilated 
common duct and air in the biliary system (arrows) are suspicious for low-grade obstruc-
t~onK (B) A percutaneous transhepatic cholangiogram performed 4 weeks posttransplanta-
bon because of persistent elevations of the serum bilirubin (8-10 mg%). At the time of 
transplantation, biliary drainage had been established with a Roux-en-Y cholecystojeju-
nostomy (FIGURE 2B). After obtaining this study, the patient was reexplored, the gall-
bladder removed, and the Roux limb anastomosed to the dilated common duct (II1rge 
41"OW), as shown in FIGURE 2C. The patient's jaundice rapidly cleared, and he now has 
normal liver function, 3 months posttransplantation. GB-gallbladder; CD-common bile 
duct; C-cystic duct. 
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remedy both the technical and bacteriologic complications associated with faulty· 
biliary reconstruction. 
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